Active

Cardiotoxicity in children and adolescents with acute leukemia: Recommendations from the Leukemia Committee of the French Society of Childhood Cancer (SFCE)

Overview

Cardiotoxicity is a significant long-term concern in children treated for leukemia, particularly with anthracyclines. Current SFCE recommendations highligh the need for early prevention, regular cardiovascular monitoring, and prompt management of cardiac complications , it support the use of dexrazoxane in patients receiving high cumulative anthracycline doses and advocate for multidisciplinary follow-up using sensitive imaging techniques to detect subclinical cardiac dysfunction at an early stage.

Discover

View our guidance library

Explore guidance for providing optimal supportive care to children receiving cancer treatments or undergoing bone marrow transplant.

Stay connected

Sign up to receive the iPOG Network quarterly newsletter!